Neil Bence
Bristol-Myers Squibb (Germany)(DE)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Prostate Cancer Treatment and Research, Estrogen and related hormone effects, Cancer-related Molecular Pathways
Most-Cited Works
- → Impairment of the Ubiquitin-Proteasome System by Protein Aggregation(2001)2,183 cited
- → Global Impairment of the Ubiquitin-Proteasome System by Nuclear or Cytoplasmic Protein Aggregates Precedes Inclusion Body Formation(2005)504 cited
- → A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment(2018)441 cited
- → Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system(2006)342 cited
- → A Rhodopsin Mutant Linked to Autosomal Dominant Retinitis Pigmentosa Is Prone to Aggregate and Interacts with the Ubiquitin Proteasome System(2002)313 cited
- → Specificity in intracellular protein aggregation and inclusion body formation(2001)233 cited
- → Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor(2017)223 cited
- → Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction(2019)203 cited
- → Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer(2021)197 cited
- → Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924(2012)108 cited